Literature DB >> 20658214

Skeletal muscle expression of bone morphogenetic protein-1 and tolloid-like-1 extracellular proteases in different fiber types and in response to unloading, food deprivation and differentiation.

David L Allen1, Bradley J Greybeck, Bradley J Greyback, Andrea M Hanson, Allison S Cleary, Sarah F Lindsay.   

Abstract

Members of the bone morphogenetic protein-1/mammalian tolloid (BMP-1/mTLD) family of proteases cleave diverse extracellular proteins, including the growth inhibitor myostatin. The purpose of this work was to examine the expression of BMP-1/mTLD, tolloid-like-1 and -2 (TLL1 and TLL2) in hindlimb muscles of the mouse in vivo and in C(2)C(12) muscle cells in vitro. Quantitative real-time polymerase chain reaction revealed that neither BMP-1/mTLD nor TLL1 mRNA levels differed between the predominantly fast-twitch tibialis anterior (TA) and gastrocnemius (GAST) muscles and the more slow-twitch soleus (SOL) muscle; TLL2 mRNA levels were not detectable in any of the muscles examined. Interestingly, however, immunohistochemical analysis revealed that BMP-1 protein was expressed in type I and IIa but not in IIb fibers. TLL1 mRNA levels significantly increased in the TA but not the SOL with 3 days of hindlimb suspension and significantly decreased in both TA and SOL in response to 2 days of food deprivation. In contrast, BMP-1/mTLD mRNA levels were unaffected in either muscle by either condition. In addition, BMP-1/mTLD and TLL1 mRNA levels significantly decreased during C(2)C(12) myoblast differentiation in vitro, and activity of a 1,200-bp mouse TLL1 promoter construct was significantly decreased in C(2)C(12) myotubes by differentiation, by mutation of an nuclear factor kappa-beta (NF-kappaB) site, or deletion of a sma/mothers against decapentaplegic (SMAD) site. Together, these data demonstrate that TLL1 mRNA levels are altered by loading, energy status, and differentiation, and thus its expression may be regulated so as to modulate activity of myostatin or other extracellular substrates during these adaptive states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658214     DOI: 10.1007/s12576-010-0104-0

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  24 in total

1.  Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles.

Authors:  K Sakuma; K Watanabe; M Sano; I Uramoto; T Totsuka
Journal:  Biochim Biophys Acta       Date:  2000-06-02

Review 2.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

3.  Myostatin levels in regenerating rat muscles and in myogenic cell cultures.

Authors:  L Mendler; E Zádor; M Ver Heyen; L Dux; F Wuytack
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

4.  Tolloid-like 1 is negatively regulated by stress and glucocorticoids.

Authors:  Goichiro Tamura; Dawne Olson; Joel Miron; Timothy G Clark
Journal:  Brain Res Mol Brain Res       Date:  2005-11-07

5.  Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors.

Authors:  David L Allen; Terry G Unterman
Journal:  Am J Physiol Cell Physiol       Date:  2006-08-02       Impact factor: 4.249

Review 6.  Potential involvement of the transcription factor NF-kappa B in neurological disorders.

Authors:  B Kaltschmidt; P A Baeuerle; C Kaltschmidt
Journal:  Mol Aspects Med       Date:  1993

7.  Mammalian BMP-1/Tolloid-related metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis.

Authors:  I C Scott; I L Blitz; W N Pappano; Y Imamura; T G Clark; B M Steiglitz; C L Thomas; S A Maas; K Takahara; K W Cho; D S Greenspan
Journal:  Dev Biol       Date:  1999-09-15       Impact factor: 3.582

8.  Embryonic expression of mouse bone morphogenetic protein-1 (BMP-1), which is related to the Drosophila dorsoventral gene tolloid and encodes a putative astacin metalloendopeptidase.

Authors:  M Fukagawa; N Suzuki; B L Hogan; C M Jones
Journal:  Dev Biol       Date:  1994-05       Impact factor: 3.582

9.  Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases.

Authors:  Neil M Wolfman; Alexandra C McPherron; William N Pappano; Monique V Davies; Kening Song; Kathleen N Tomkinson; Jill F Wright; Liz Zhao; Suzanne M Sebald; Daniel S Greenspan; Se-Jin Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

10.  Bone morphogenetic protein-1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues.

Authors:  K Takahara; G E Lyons; D S Greenspan
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

View more
  4 in total

Review 1.  Is there a role for endogenous retroviruses to mediate long-term adaptive phenotypic response upon environmental inputs?

Authors:  Jafar Sharif; Yoichi Shinkai; Haruhiko Koseki
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 2.  Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting.

Authors:  Astrid Breitbart; Mannix Auger-Messier; Jeffery D Molkentin; Joerg Heineke
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

3.  Matrix metalloproteinase-9 deficiency results in decreased fiber cross-sectional area and alters fiber type distribution in mouse hindlimb skeletal muscle.

Authors:  Ryan S Mehan; Bradley J Greybeck; Kayla Emmons; William C Byrnes; David L Allen
Journal:  Cells Tissues Organs       Date:  2011-03-09       Impact factor: 2.481

4.  Schisandrae Fructus Supplementation Ameliorates Sciatic Neurectomy-Induced Muscle Atrophy in Mice.

Authors:  Joo Wan Kim; Sae-Kwang Ku; Ki Young Kim; Sung Goo Kim; Min Ho Han; Gi-Young Kim; Hye Jin Hwang; Byung Woo Kim; Cheol Min Kim; Yung Hyun Choi
Journal:  Oxid Med Cell Longev       Date:  2015-05-12       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.